GLOBAL ANTIHISTAMINE DRUGS MARKET Size and trends

Global Antihistamine Drugs Market Size and Trends

The antihistamine drugs market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

To learn more about this report, Request sample copy

The antihistamine drugs market has been witnessing a growing trend of development of advanced formulations. Traditionally, antihistamine drugs were available in the form tablets and capsules. However, consumption of tablets and capsules requires water, which may not always be available, especially in outdoor activities involving allergy sufferers.

To overcome this limitation, market players are focusing on developing advanced formulations such as sprays, creams and wipes to provide convenience of use. This has been a major trend revolutionizing use of antihistamines. Development of advanced formulations is expected to drive future growth opportunities in antihistamine drugs market over the forecasted period.

Rising prevalence of allergic diseases

The global prevalence of allergic diseases and disorders has been increasing significantly over the past few decades. Allergic rhinitis, commonly known as hay fever, is a very common medical condition that affects both children and adults. It occurs when the immune system overreacts to allergens in the air like pollen, dust mites, pet dander, or mold. According to an article published by the European government in July 2022, about 150 million people in Europe live with an allergic condition, such as allergic rhinitis, asthma, atopic eczema, or a food allergy. The growing environmental pollution and changes in lifestyle and diet are believed to be major factors contributing to the heightened risk of developing allergic conditions. As antihistamine drugs are currently the most effective pharmacological treatment for relieving symptoms of allergies like sneezing, itchy and watery eyes, it is expected that the rising disease prevalence will drive steady demand for these medications in the coming years.